Open AccessEdoxaban treatment for pulmonary arterial thromboembolism associated with azygous vein aneurysm
Author(s) -
Mochimaru Takao,
Kawada Ichiro,
Chubachi Shotaro,
Tsutsumi Akihiro,
Hasegawa Hanako,
Betsuyaku Tomoko
Publication year - 2017
Publication title -
respirology case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 9
ISSN - 2051-3380
DOI - 10.1002/rcr2.223
Subject(s) - medicine , edoxaban , aneurysm , pulmonary embolism , asymptomatic , thrombus , radiology , vein , surgery , cardiology , warfarin , atrial fibrillation , dabigatran
A 76‐year‐old woman, diagnosed 5 years previously with an asymptomatic mediastinal bronchogenic cyst, was referred to our department as the mass had grown slightly larger. Contrast‐enhanced computed tomography and magnetic resonance imaging scans revealed an azygous vein aneurysm with a pulmonary arterial thromboembolism. The patient was treated with heparin for 5 days, and anticoagulation therapy with edoxaban was continued for 12 months. The thrombus resolved, and the aneurysm remained unchanged. An azygous vein aneurysm is a very rare condition that causes pulmonary arterial thromboembolism. Although surgical resection is indicated for patients with azygous vein aneurysms with a risk of rupture and pulmonary embolism, we chose anticoagulation therapy because of the patient's advanced age. This case suggests that the azygous vein aneurysm is one of the differential diagnoses for a mediastinal mass and that anticoagulation therapy can be the treatment of choice for pulmonary arterial thromboembolism with an azygous vein aneurysm.